Trials / Completed
CompletedNCT05600101
Development and Piloting an Avatar-based Intervention to Support Patients Undergoing Stem Cell Transplantation
Development of Avatar-based Intervention to Support Patients Undergoing Reduced-Intensity Allogenic Stem Cell Transplantation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Dana-Farber Cancer Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this research study is to provide an avatar-based technology during a subject's stay for participants who have been admitted to the hospital for reduced-intensity conditioning (RIC) allogeneic transplant. The intervention received will be the care.coach technology.
Detailed description
This research study is a Pilot Study, which means the investigators are studying the application in a smaller group of people to understand whether the technology, care.coach, is easy to use. This is a single site study at Dana-Farber Brigham and Women's Cancer Center. * Aim 1 of the study will be an 8 - 10 participant focus group of nurses, navigator nurses, physicians, and NPs/PAs to refine the avatar protocols. * Aim 2 of the study will be a pilot of 18 participants undergoing RIC allogeneic HCT in the hospital. * The research study procedures include screening for eligibility, a brief call with a research assistant during use of care.coach avatar, and a survey after study completion. * The avatar is designed to communicate with participants regarding transplantation education and provide reminders for eating, drinking, and activity. * care.coach is a digital, avatar-based technology that communicates using natural speech software. * care.coach is supporting this research by providing Dana-Farber access to its technology. The National Cancer Institute (NCI) also supports this research.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Care.Coach | Care.coach is a "human-in the-loop" conversational agent (avatar) used to interact and converse with patients through natural dialogue and text-to-speech software that is powered by a team of trained human staff, called health advocates. |
Timeline
- Start date
- 2022-12-06
- Primary completion
- 2023-05-10
- Completion
- 2023-05-16
- First posted
- 2022-10-31
- Last updated
- 2024-07-03
- Results posted
- 2024-07-03
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05600101. Inclusion in this directory is not an endorsement.